Sectors

At-home fitness company Mirror is set to be acquired by Lululemon for $500m, after the corporate contributed to its series B round in November.

Existing backer Legend Capital contributed to an eight-figure dollar round for the Tsinghua-backed chemistry services provider.

The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Digital payment management platform Beyonic, a graduate of Barclays and Techstars' Cape Town accelerator, has been purchased.

Sinopec Capital and Meinian Onehealth both invested in the biotech research product maker as it prepares for an initial public offering.

Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.

Index Ventures participated in a round that valued the WarnerMedia and Tencent-backed communication platform developer at $3.5bn.

Home urinalysis test provider Inui had raised $50m from investors including Fosun and Tencent but is being bought by peer Healthy.io for just $9m.

Trading bourse owner SGX will take over the remaining 80% of the FX trading platform operator, its Asian Gateway Investments vehicle having invested $25m last year.

Samsung Catalyst Fund, BBVA, SBI Group and ABN Amro Ventures chipped in as the banking platform developer raised $67.3m at a $360m valuation.